NASDAQ:TRIV - Trivascular Technologies Stock Price, Price Target & More

$5.87 +0.42 (+7.71 %)
(As of 04/24/2018 10:24 AM ET)
Previous Close$5.45
Today's Range$5.31 - $5.95
52-Week Range$3.98 - $11.49
Volume24,500 shs
Average Volume18,900 shs
Market Capitalization$120.75 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies logoTrivascular Technologies, Inc. is a medical device company developing and commercializing technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The Ovation System, the Company's solution for the treatment of AAA through minimally invasive endovascular aortic repair, or EVAR, is a stent graft platform, providing an alternative to conventional devices. It is designed to specifically address many of the limitations associated with conventional EVAR devices and expand the pool of patients eligible for EVAR. The Company is developing Ovation iX iliac limbs for use with both its Ovation Prime and its Ovation iX and Alto aortic bodies, which are in development. Trivascular is developing Ovation iX aortic bodies for use with both its Ovation Prime and its Ovation iX iliac limbs. The Company is developing an aortic body that together with the iliac limbs makes up the Ovation Alto stent graft.

Receive TRIV News and Ratings via Email

Sign-up to receive the latest news and ratings for TRIV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:TRIV
CUSIPN/A
Webwww.trivascular.com
Phone+1-707-5438800

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-143.61%
Return on Equity-766.90%
Return on Assets-66.97%

Miscellaneous

EmployeesN/A
Outstanding Shares20,520,000

How to Become a New Pot Stock Millionaire

Trivascular Technologies (NASDAQ:TRIV) Frequently Asked Questions

What is Trivascular Technologies' stock symbol?

Trivascular Technologies trades on the NASDAQ under the ticker symbol "TRIV."

How were Trivascular Technologies' earnings last quarter?

Trivascular Technologies Inc (NASDAQ:TRIV) released its earnings results on Monday, November, 9th. The medical device company reported ($0.66) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.71) by $0.05. The medical device company had revenue of $9.50 million for the quarter, compared to analyst estimates of $9.28 million. Trivascular Technologies had a negative net margin of 143.61% and a negative return on equity of 766.90%. Trivascular Technologies's revenue for the quarter was up 20.3% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.69) earnings per share. View Trivascular Technologies' Earnings History.

Has Trivascular Technologies been receiving favorable news coverage?

News stories about TRIV stock have been trending somewhat positive on Tuesday, Accern reports. The research firm ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Trivascular Technologies earned a daily sentiment score of 0.24 on Accern's scale. They also gave news headlines about the medical device company an impact score of 45.04 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of Trivascular Technologies?

Shares of TRIV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Trivascular Technologies' stock price today?

One share of TRIV stock can currently be purchased for approximately $5.87.

How big of a company is Trivascular Technologies?

Trivascular Technologies has a market capitalization of $120.75 million.

How can I contact Trivascular Technologies?

Trivascular Technologies' mailing address is 3910 Brickway Blvd, SANTA ROSA, CA 95403-1070, United States. The medical device company can be reached via phone at +1-707-5438800.


MarketBeat Community Rating for Trivascular Technologies (TRIV)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  93 (Vote Outperform)
Underperform Votes:  63 (Vote Underperform)
Total Votes:  156
MarketBeat's community ratings are surveys of what our community members think about Trivascular Technologies and other stocks. Vote "Outperform" if you believe TRIV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRIV will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Trivascular Technologies (NASDAQ:TRIV) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/24/2016 forward)

Earnings

Trivascular Technologies (NASDAQ:TRIV) Earnings History and Estimates Chart

Earnings by Quarter for Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies (NASDAQ TRIV) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2015Q3($0.71)($0.66)$9.28 million$9.50 millionViewN/AView Earnings Details
8/4/2015Q215($0.73)($0.73)$8.78 million$9.70 millionViewN/AView Earnings Details
5/5/2015Q115($0.68)($0.77)$8.48 million$9.00 millionViewListenView Earnings Details
3/3/2015Q414($0.65)($0.72)$9.54 million$9.10 millionViewListenView Earnings Details
11/10/2014Q314($0.63)($0.69)$7.90 million$7.88 millionViewN/AView Earnings Details
8/6/2014Q214($0.66)($0.87)$7.54 million$7.80 millionViewN/AView Earnings Details
5/14/2014Q1 14($1.10)($1.17)$6.90 million$7.00 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Trivascular Technologies (NASDAQ:TRIV) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Trivascular Technologies (NASDAQ TRIV) Insider Trading and Institutional Ownership History

Insider Trading History for Trivascular Technologies (NASDAQ:TRIV)

Trivascular Technologies (NASDAQ TRIV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/22/2014Douglas A RoederDirectorBuy833,333$12.00$9,999,996.00View SEC Filing  
4/22/2014Enterprise Associates 12 NewMajor ShareholderBuy583,333$12.00$6,999,996.00View SEC Filing  
4/22/2014James E FlynnInsiderBuy1,065,000$12.01$12,790,650.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Trivascular Technologies (NASDAQ TRIV) News Headlines

Source:
DateHeadline
John McDermott Steps Down as Chief Executive Officer of Endologix, Inc.John McDermott Steps Down as Chief Executive Officer of Endologix, Inc.
finance.yahoo.com - February 21 at 4:40 PM
Contrasting Trivascular Technologies (TRIV) and Amedica (AMDA)Contrasting Trivascular Technologies (TRIV) and Amedica (AMDA)
www.americanbankingnews.com - January 26 at 11:08 PM
Head to Head Analysis: Trivascular Technologies (TRIV) vs. Its CompetitorsHead to Head Analysis: Trivascular Technologies (TRIV) vs. Its Competitors
www.americanbankingnews.com - January 21 at 9:06 PM
Analyzing Trivascular Technologies (TRIV) and Its CompetitorsAnalyzing Trivascular Technologies (TRIV) and Its Competitors
www.americanbankingnews.com - January 20 at 9:14 PM
Trivascular Technologies (TRIV) vs. Its Rivals Head-To-Head ReviewTrivascular Technologies (TRIV) vs. Its Rivals Head-To-Head Review
www.americanbankingnews.com - January 20 at 9:14 PM
Financial Contrast: Trivascular Technologies (TRIV) versus Its RivalsFinancial Contrast: Trivascular Technologies (TRIV) versus Its Rivals
www.americanbankingnews.com - January 20 at 3:16 AM
Comparing Trivascular Technologies (TRIV) & Its CompetitorsComparing Trivascular Technologies (TRIV) & Its Competitors
www.americanbankingnews.com - January 19 at 3:32 AM
Head to Head Survey: Trivascular Technologies (TRIV) vs. Its CompetitorsHead to Head Survey: Trivascular Technologies (TRIV) vs. Its Competitors
www.americanbankingnews.com - January 18 at 11:18 AM
Financial Contrast: Trivascular Technologies (TRIV) and Its PeersFinancial Contrast: Trivascular Technologies (TRIV) and Its Peers
www.americanbankingnews.com - January 17 at 3:18 PM
Comparing Trivascular Technologies (TRIV) and Its RivalsComparing Trivascular Technologies (TRIV) and Its Rivals
www.americanbankingnews.com - January 17 at 11:40 AM
Trivascular Technologies (TRIV) & Its Rivals Head-To-Head ReviewTrivascular Technologies (TRIV) & Its Rivals Head-To-Head Review
www.americanbankingnews.com - January 17 at 8:20 AM
Trivascular Technologies (TRIV) versus The Competition Critical ReviewTrivascular Technologies (TRIV) versus The Competition Critical Review
www.americanbankingnews.com - January 16 at 7:34 AM
Critical Contrast: Trivascular Technologies (TRIV) vs. Its CompetitorsCritical Contrast: Trivascular Technologies (TRIV) vs. Its Competitors
www.americanbankingnews.com - January 15 at 5:08 PM
Trivascular Technologies (TRIV) vs. The Competition Head to Head SurveyTrivascular Technologies (TRIV) vs. The Competition Head to Head Survey
www.americanbankingnews.com - January 15 at 3:32 AM
Head-To-Head Review: Trivascular Technologies (TRIV) vs. Its CompetitorsHead-To-Head Review: Trivascular Technologies (TRIV) vs. Its Competitors
www.americanbankingnews.com - January 14 at 5:34 PM
Trivascular Technologies (TRIV) vs. Its Competitors Head-To-Head ComparisonTrivascular Technologies (TRIV) vs. Its Competitors Head-To-Head Comparison
www.americanbankingnews.com - January 14 at 9:30 AM
Trivascular Technologies (TRIV) vs. Its Peers Head to Head ReviewTrivascular Technologies (TRIV) vs. Its Peers Head to Head Review
www.americanbankingnews.com - January 13 at 1:34 PM
Trivascular Technologies (TRIV) and The Competition Critical ContrastTrivascular Technologies (TRIV) and The Competition Critical Contrast
www.americanbankingnews.com - January 13 at 9:26 AM
Head-To-Head Analysis: Trivascular Technologies (TRIV) and Its RivalsHead-To-Head Analysis: Trivascular Technologies (TRIV) and Its Rivals
www.americanbankingnews.com - January 12 at 7:02 PM
Trivascular Technologies (TRIV) versus The Competition Head to Head AnalysisTrivascular Technologies (TRIV) versus The Competition Head to Head Analysis
www.americanbankingnews.com - January 12 at 8:02 AM
Head-To-Head Analysis: Trivascular Technologies (TRIV) vs. Its PeersHead-To-Head Analysis: Trivascular Technologies (TRIV) vs. Its Peers
www.americanbankingnews.com - January 12 at 8:02 AM
Critical Contrast: Trivascular Technologies (TRIV) & The CompetitionCritical Contrast: Trivascular Technologies (TRIV) & The Competition
www.americanbankingnews.com - January 10 at 11:14 PM
Contrasting Trivascular Technologies (TRIV) & Its PeersContrasting Trivascular Technologies (TRIV) & Its Peers
www.americanbankingnews.com - January 10 at 5:30 PM
Financial Comparison: Trivascular Technologies (TRIV) and Its RivalsFinancial Comparison: Trivascular Technologies (TRIV) and Its Rivals
www.americanbankingnews.com - January 9 at 8:08 AM
Trivascular Technologies (TRIV) vs. The Competition Head-To-Head AnalysisTrivascular Technologies (TRIV) vs. The Competition Head-To-Head Analysis
www.americanbankingnews.com - January 9 at 5:10 AM
Trivascular Technologies (TRIV) vs. The Competition Financial ComparisonTrivascular Technologies (TRIV) vs. The Competition Financial Comparison
www.americanbankingnews.com - January 8 at 11:06 PM
Reviewing Trivascular Technologies (TRIV) & Its PeersReviewing Trivascular Technologies (TRIV) & Its Peers
www.americanbankingnews.com - January 8 at 12:04 PM
Analyzing Trivascular Technologies (TRIV) & Its CompetitorsAnalyzing Trivascular Technologies (TRIV) & Its Competitors
www.americanbankingnews.com - January 6 at 3:36 PM
Head to Head Review: Trivascular Technologies (TRIV) versus Its PeersHead to Head Review: Trivascular Technologies (TRIV) versus Its Peers
www.americanbankingnews.com - January 5 at 1:40 PM
Head to Head Review: Trivascular Technologies (TRIV) vs. Its PeersHead to Head Review: Trivascular Technologies (TRIV) vs. Its Peers
www.americanbankingnews.com - January 4 at 3:32 AM
Trivascular Technologies (TRIV) vs. Its Peers Financial AnalysisTrivascular Technologies (TRIV) vs. Its Peers Financial Analysis
www.americanbankingnews.com - January 3 at 7:06 PM
Trivascular Technologies (TRIV) vs. The Competition Financial AnalysisTrivascular Technologies (TRIV) vs. The Competition Financial Analysis
www.americanbankingnews.com - January 1 at 9:10 PM
Critical Review: Trivascular Technologies (TRIV) and Its PeersCritical Review: Trivascular Technologies (TRIV) and Its Peers
www.americanbankingnews.com - January 1 at 9:26 AM
Critical Review: Trivascular Technologies (TRIV) versus The CompetitionCritical Review: Trivascular Technologies (TRIV) versus The Competition
www.americanbankingnews.com - January 1 at 7:28 AM
Head-To-Head Review: Trivascular Technologies (TRIV) and The CompetitionHead-To-Head Review: Trivascular Technologies (TRIV) and The Competition
www.americanbankingnews.com - December 29 at 5:28 PM
Contrasting RTI Surgical (RTIX) & Trivascular Technologies (TRIV)Contrasting RTI Surgical (RTIX) & Trivascular Technologies (TRIV)
www.americanbankingnews.com - December 29 at 3:24 PM
Financial Contrast: Trivascular Technologies (TRIV) versus The CompetitionFinancial Contrast: Trivascular Technologies (TRIV) versus The Competition
www.americanbankingnews.com - December 28 at 12:16 AM
Trivascular Technologies (TRIV) versus The Competition Financial ContrastTrivascular Technologies (TRIV) versus The Competition Financial Contrast
www.americanbankingnews.com - December 27 at 3:54 PM
Financial Review: Trivascular Technologies (TRIV) and Its RivalsFinancial Review: Trivascular Technologies (TRIV) and Its Rivals
www.americanbankingnews.com - December 27 at 5:34 AM
Analyzing Trivascular Technologies (TRIV) & The CompetitionAnalyzing Trivascular Technologies (TRIV) & The Competition
www.americanbankingnews.com - December 26 at 3:28 PM
Reviewing Trivascular Technologies (TRIV) and Its RivalsReviewing Trivascular Technologies (TRIV) and Its Rivals
www.americanbankingnews.com - December 25 at 11:06 AM
Financial Review: Trivascular Technologies (TRIV) & Its PeersFinancial Review: Trivascular Technologies (TRIV) & Its Peers
www.americanbankingnews.com - December 25 at 8:20 AM
Critical Contrast: Trivascular Technologies (TRIV) and Its PeersCritical Contrast: Trivascular Technologies (TRIV) and Its Peers
www.americanbankingnews.com - December 25 at 3:28 AM
Trivascular Technologies (TRIV) & Endologix (ELGX) Head to Head ReviewTrivascular Technologies (TRIV) & Endologix (ELGX) Head to Head Review
www.americanbankingnews.com - December 24 at 1:32 PM
Trivascular Technologies (TRIV) versus Its Peers Critical ReviewTrivascular Technologies (TRIV) versus Its Peers Critical Review
www.americanbankingnews.com - December 24 at 1:32 PM
Head to Head Comparison: Trivascular Technologies (TRIV) vs. The CompetitionHead to Head Comparison: Trivascular Technologies (TRIV) vs. The Competition
www.americanbankingnews.com - December 24 at 8:05 AM
Trivascular Technologies (TRIV) & Its Peers Critical ContrastTrivascular Technologies (TRIV) & Its Peers Critical Contrast
www.americanbankingnews.com - December 23 at 5:24 PM
Reviewing Trivascular Technologies (TRIV) and Its PeersReviewing Trivascular Technologies (TRIV) and Its Peers
www.americanbankingnews.com - December 23 at 1:24 AM
Contrasting Trivascular Technologies (TRIV) & Its RivalsContrasting Trivascular Technologies (TRIV) & Its Rivals
www.americanbankingnews.com - December 23 at 1:24 AM
Contrasting ConforMIS (CFMS) and Trivascular Technologies (TRIV)Contrasting ConforMIS (CFMS) and Trivascular Technologies (TRIV)
www.americanbankingnews.com - November 20 at 11:19 AM

SEC Filings

Trivascular Technologies (NASDAQ:TRIV) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Trivascular Technologies (NASDAQ TRIV) Stock Chart for Tuesday, April, 24, 2018

Loading chart…

This page was last updated on 4/24/2018 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.